Redefining mesenchymal stem cells: using their cellular and molecular phenotypes to determine their regenerative and therapeutic properties

重新定义间充质干细胞:利用其细胞和分子表型来确定其再生和治疗特性

基本信息

  • 批准号:
    10468688
  • 负责人:
  • 金额:
    $ 43.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Mesenchymal stem cells (MSCs) have broad-based potential in regenerative medicine cell therapies and can be isolated from a variety of different tissues. Though MSCs from different tissues are phenotypically similar, a barrier to their clinical use is the high variability of their trophic and regenerative properties. This variability suggests that inherent differences exist in the molecular machinery guiding MSC properties between different MSC populations, yet, to date, these differences are ill-defined. To this end, we have preliminary evidence that MSC phenotypes correlate to their regenerative outcomes. In this study, we aim to elucidate how the molecular and cellular properties of distinct MSC populations determine their regenerative properties. Our hypothesis is that MSCs from different tissues have different regenerative properties which correlate to specific molecular profiles defined by gene expression and transcriptional activity. To test this hypothesis, the project proposed has three Specific Aims (SAs). In SA1, we will determine how tissue-specificity dictates gene expression and dynamic transcription factor activity of distinct MSCs. SA2 will determine how differences in the cellular and molecular properties of MSCs correlate to MSC phenotype. Finally, in SA3, we will determine how the molecular profiles and cellular activities of MSCs dictate their regenerative properties. Findings of the proposed study will provide novel insights about how the distinct molecular profiles of MSCs dictate their biological and physiological properties. In a therapeutic context, this would enable the development of innovative screening technologies for MSC therapies to identify and enrich for the most appropriate MSC for the specific therapeutic application.
摘要 间充质干细胞(MSCs)在再生医学细胞治疗和治疗中具有广泛的潜力 可以从各种不同的组织中分离出来。尽管来自不同组织的MSCs具有表型 同样,它们临床应用的障碍是它们的营养和再生特性的高度可变性。这 可变性表明,指导MSC特性的分子机制存在固有的差异 然而,到目前为止,这些差异在不同的MSC群体之间还没有明确的定义。为此,我们有 初步证据表明,MSC表型与其再生结果相关。在本研究中,我们的目标是 为了阐明不同MSC群体的分子和细胞特性如何决定他们的 再生特性。我们的假设是来自不同组织的MSCs具有不同的再生能力 与由基因表达和转录所定义的特定分子图谱相关的特性 活动。为了验证这一假设,提出的项目有三个具体目标(SA)。在SA1中,我们将 确定组织特异性如何决定基因表达和动态转录因子活性 不同的骨髓间充质干细胞。SA2将决定细胞和分子特性的差异如何 MSCs与MSC表型相关。最后,在SA3中,我们将确定分子轮廓和 MSCs的细胞活动决定了它们的再生特性。拟议研究的结果将 提供关于MSCs的不同分子特征如何决定其生物学和 生理特性。在治疗方面,这将使创新的发展成为可能 MSC疗法的筛选技术,以确定和丰富最适合的MSC 具体的治疗应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DARNELL KAIGLER其他文献

DARNELL KAIGLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DARNELL KAIGLER', 18)}}的其他基金

Redefining mesenchymal stem cells: using their cellular and molecular phenotypes to determine their regenerative and therapeutic properties
重新定义间充质干细胞:利用其细胞和分子表型来确定其再生和治疗特性
  • 批准号:
    10231011
  • 财政年份:
    2019
  • 资助金额:
    $ 43.47万
  • 项目类别:
Redefining mesenchymal stem cells: using their cellular and molecular phenotypes to determine their regenerative and therapeutic properties
重新定义间充质干细胞:利用其细胞和分子表型来确定其再生和治疗特性
  • 批准号:
    10687814
  • 财政年份:
    2019
  • 资助金额:
    $ 43.47万
  • 项目类别:
Customized craniofacial stem cell therapy for craniofacial bone defects
颅面骨缺损定制颅面干细胞治疗
  • 批准号:
    9135822
  • 财政年份:
    2015
  • 资助金额:
    $ 43.47万
  • 项目类别:
Customized craniofacial stem cell therapy for craniofacial bone defects
颅面骨缺损的定制颅面干细胞治疗
  • 批准号:
    9147559
  • 财政年份:
    2015
  • 资助金额:
    $ 43.47万
  • 项目类别:
Alveolar Bone Marrow Derived Stem Cells for Clinical Cell Therapy
用于临床细胞治疗的肺泡骨髓干细胞
  • 批准号:
    8733350
  • 财政年份:
    2013
  • 资助金额:
    $ 43.47万
  • 项目类别:
INDIVIDUAL PREDOCTORAL DENTAL SCIENTIST FELLOWSHIP
个人博士前牙科科学家奖学金
  • 批准号:
    6634592
  • 财政年份:
    2002
  • 资助金额:
    $ 43.47万
  • 项目类别:
INDIVIDUAL PREDOCTORAL DENTAL SCIENTIST FELLOWSHIP
个人博士前牙科科学家奖学金
  • 批准号:
    6705025
  • 财政年份:
    2002
  • 资助金额:
    $ 43.47万
  • 项目类别:
INDIVIDUAL PREDOCTORAL DENTAL SCIENTIST FELLOWSHIP
个人博士前牙科科学家奖学金
  • 批准号:
    6516371
  • 财政年份:
    2002
  • 资助金额:
    $ 43.47万
  • 项目类别:
INDIVIDUAL PREDOCTORAL DENTAL SCIENTIST FELLOWSHIP
个人博士前牙科科学家奖学金
  • 批准号:
    6397736
  • 财政年份:
    2001
  • 资助金额:
    $ 43.47万
  • 项目类别:
INDIVIDUAL PREDOCTORAL DENTAL SCIENTIST FELLOWSHIP
个人博士前牙科科学家奖学金
  • 批准号:
    6135369
  • 财政年份:
    2000
  • 资助金额:
    $ 43.47万
  • 项目类别:

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 43.47万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 43.47万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 43.47万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 43.47万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 43.47万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 43.47万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 43.47万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 43.47万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 43.47万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 43.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了